Park, Kyung <br/><br/>
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2014 
 - 206-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2013.49.8386  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Biopsy<br/>Disease Progression<br/>Gene Expression Regulation, Neoplastic<br/>Gene Fusion<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Oncogene Proteins, Fusion--genetics<br/>Prostatic Intraepithelial Neoplasia--diagnosis<br/>Prostatic Neoplasms--diagnosis<br/>Toremifene--therapeutic use<br/>Up-Regulation